AESTHETIC NEWSAESTHETIC NEWS

Premium Healthcare Beacon Campus is the first medical institute in the nation to deploy SENSORA™ Cardiac Disease Platform by Eko Health to identify structural heart disease

Premium Healthcare SENSORA\u2122 Screening
Valerie Rodriguez MSN, APRN, FNP-BC co-founder of Premium Healthcare’s Cardiac Department conducting a SENSORA\u2122 Screening on a female patient.

MIAMI, April 6, 2023 (Newswire.com)
–
Premium Healthcare has announced the implementation of SENSORA™ Cardiac Disease Detection Platform by Eko Health to identify structural heart disease. With the launch of Eko Health technology, Premium Healthcare is advancing the way to more accurately and consistently identify valvular heart disease (VHD) in patients during routine visits with their primary care physician (PCP).

“I was brought in to use this advanced new equipment. In what felt like a few moments I was done and received my results immediately. It was a painless quick procedure. Thank god everything is great, and I don’t have anything to worry about,” said Oscar Peñaber, a 72-year-old patient at Premium Healthcare Plus Senior Medical Center. 

By combining murmur analysis artificial intelligence (AI) with its digital stethoscopes, Eko Health has pioneered a non-invasive detection platform that can identify structural murmurs in seconds, so patients can get the treatment they need sooner. Premium Healthcare is the first healthcare institution in the United States to deploy SENSORA™ for structural murmur detection, which was recently cleared by the U.S. Food and Drug Administration (FDA).  

VHD, the most common type of structural heart disease, is a life-threatening condition diagnosed in more than 8 million Americans. Left undetected and untreated, it can lead to heart failure, stroke, blood clots, and death. Older adults have approximately a 1 in 10 chance of developing clinically significant VHD. However, more than half (57%) of clinically significant valvular heart disease goes undetected in this population. SENSORA™ for structural murmur detection more than doubles the likelihood of detecting significant VHD.

“The primary care setting is a patient’s first line of defense for identifying and diagnosing heart disease. However, we know from clinical evidence that detection rates are low,” said Dr. Keila Hoover M.D, Founder and CEO of Premium Healthcare. “We’re excited about the promise of this technology to better serve our patient community by increasing the accuracy and consistency of structural murmur identification and improving the quality of referrals for valve disease treatment.”

Premium Healthcare will debut the use of SENSORA™ for structural murmur detection at their newly opened 5-story tower building, Beacon Campus, on 69^th Ave SW Coral Way and their Senior Medical Center in the heart of Westchester, FL.

Premium Healthcare is South Florida’s fastest-growing medical centers, and their introduction of Eko Health’s SENSORA™ Platform at the Beacon Campus is evidence of the medical organization’s commitment to fast-paced technological advancements.

For more information about SENSORA™ at Premium Healthcare call 786-523-3836 or visit premiumhealthcare.com.

Contact Information:

Daniel Gonzalez

Marketing Manager

[email protected]

(786)523-3836

Carlos De Cespedes

Co Owner of Premium Healthcare Plus Senior Medical Center

[email protected]

(305)586-1234

Original Source:

Premium Healthcare First in the Nation to Debut AI Powered Heart Valve Disease Detection Program

TIFF Bell Lightbox will be the site for health IT adventurers this spring at Smile Digital Health’s first-ever in-person IHD.

TORONTO, April 6, 2023 (Newswire.com)
–
Smile Digital Health (Smile), a leading FHIR® health data fabric and exchange solutions provider, announced on Jan. 25, 2023, that its annual Intelligent Health Data (IHD) Symposium will be taking place in Toronto at TIFF Bell Lightbox on May 15 – 16. This is in addition to its traditional virtual offering. TIFFs unique atmosphere lends itself to networking opportunities, heightening the overall attendee experience.

The Hon. Sylvia Jones, Ontario’s Deputy Premier and Minister of Health, is the event’s featured keynote speaker. Minister Jones has worked with healthcare partners from across Ontario, championing initiatives to advance easier and faster access to care along with creating additional options for care in each community. Her passion and advocacy for building a more convenient and connected healthcare system stem from her belief that putting the patient back at the center of healthcare is the key to the future. Minister Jones will share her insights on the future of healthcare in Ontario.

The third annual symposium provides attendees the opportunity to take a health data adventure of their own making, with three theaters and over 20 sessions to choose from. Presented by a host of industry leaders, session topics cover current health data innovations and solutions to a range of pertinent industry concerns, such as Overview of the Shared pan-Canadian Interoperability Roadmap; Large Language Models in Healthcare; AI in Healthcare: Identifying the Opportunities in Healthcare by Understanding the Job of Healthcare and Wearables on FHIR: How best to represent time-series data in the FHIR standard. The full agenda can be found on the IHD website.

“Hosting an event like IHD helps drive that collaboration in the health IT community that is so integral to achieving better global health. We appreciate having the opportunity to hold such an event and are thrilled that Minister Jones will set the stage for two days of learning, networking and idea sharing,” said Duncan Weatherston, Chief Executive Officer, Smile Digital Health. “This event underscores Smile’s commitment to building a world-class learning health system across Ontario.” 

The symposium’s platinum sponsor, Accenture, is a Fortune Global 500 company specializing in information technology services and consulting.

“Helping to foster innovation and growth in the community and working with a partner like Smile Digital Health make being part of an event like IHD an easy decision. Our goal is to create 360° Value for all our stakeholders—our clients, people, shareholders, partners and communities. Bringing the health IT community together is one way we can do just that,” said Karina Guy, Managing Director and National Lead, Applied Intelligence in Health Care and Life Sciences, Accenture (Canada).

Attendees visiting Toronto, the third largest tech hub in North America, can enjoy a preferred room rate at the Hyatt Regency Hotel as long as they book by April 13, 2023.

Changes in the digital health landscape are happening at hyperspeed. Smile wants to share their journey on the road to digital transformation in healthcare. IHD 2023 is one step along the way. Guests can register on the IHD website.

###

About Smile Digital Health

Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, open framework data fabric and integration platform fuels healthcare’s digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate and meaningfully share the health information to power digital transformation. We prepare healthcare providers, payers, researchers and life sciences organizations for a connected future beyond legacy systems, adding new value through the intelligent use of information, and ultimately delivering better patient outcomes. For more information, visit SmileDigitalHealth.com. 

Contact Information:

Victoria Valladolid

Director of Marketing, Smile Digital Health

[email protected]

(877) 537-3343 x 728

Original Source:

The Intelligent Health Data Symposium Goes Hybrid

Network of high-quality research sites will leverage endoscopy AI platform to expand and accelerate enrollment in gastroenterology clinical trials.

…

First Study of Its Kind Outlines Symptoms and Uncovers Proactive Steps Patients Can Take to Get Treatment

Auditory Processing Institute
logo for Auditory Processing Institute

SUNSHINE COAST, Australia, April 5, 2023 (Newswire.com)
–
Long COVID “brain fog” symptoms are linked to auditory processing disorder (APD), an underdiagnosed neurological disorder, suggests a new study from the Auditory Processing Institute of Queensland, Australia, published today in The Hearing Journal. Authored by renowned audiologists Dr. Robert DiSogra and Dr. Angela Loucks Alexander, whose recent TEDx Talk generated more than one million views, the study found that patients can be treated effectively with existing interventions. Unfortunately, APD symptoms can easily be confused with other hearing or neurological issues, so people with these symptoms should proactively talk to their doctors about getting APD testing. 

APD occurs when a patient’s brain has trouble understanding what they hear into usable information, making it difficult to understand and communicate with others. Untreated patients can quickly suffer serious consequences, including an inability to connect with others, strained relationships, poor job performance, and depression. 

“We’ve seen an uptick in patients whose symptoms started after a COVID-19 diagnosis but testing for an auditory processing disorder is rarely recommended. As a result of this study, we can confidently tell people with “brain fog” symptoms to get tested for APD,” says Dr. Angela Loucks Alexander, Director of the Auditory Processing Institute. “Early testing is a simple step that would have saved many of our patients a lot of distress and provided them with treatment much sooner.”

Because “brain fog” symptoms may be caused by a wide variety of neurological and other medical conditions, APD can be overlooked. For patients searching for answers, APD testing could open a new pathway to recovery.

APD patients may experience trouble understanding people when there is background noise, often find that they need information repeated multiple times, and might have trouble remembering what was said to them. The good news is that while it is not widely known to the public, auditory processing disorder is both easy to test for and highly treatable. 

“This is the first end-to-end scientific case study of its kind evaluating a patient’s diagnosis and progress — providing a road map from diagnosis to recovery. It tells us that existing treatments can have excellent results for patients who are experiencing APD symptoms after COVID-19,” said Dr. Robert DiSogra, an Audiology consultant in Millstone, New Jersey. “We hope to see more research as a result of this study.”

Study Summary

Patients who have experienced COVID-19 and are now complaining of “brain fog” may suffer from an Auditory Processing Disorder (APD). 

The Auditory Processing Institute in Queensland, Australia, reported a case study involving a physician without hearing complaints before COVID-19 infection. After tests were administered, it was found that the patient had a significantly impaired ability to understand speech in noise in both ears. Through systematic auditory training, the patient showed significant improvement on all tests after just 12 sessions and resolved his chief complaint of difficulty hearing in noise in a crowded environment. These results suggest that current techniques used in these test batteries can help diagnose an APD related to post-COVID-19 “brain fog” and manage those patients as effectively as non-COVID-19 sufferers.

The authors recommend that people with post-COVID-19 “brain fog” should have an audiologist evaluate their hearing and listening abilities.   

People experiencing “brain fog” symptoms should take this survey and talk to their doctor about APD if any of these scenarios seem familiar:

• Does any difficulty with your hearing or listening limit your personal or social life?
• Does a hearing or listening problem cause you difficulty when in a restaurant with relatives or friends?
• Does a hearing or listening problem cause you to feel left out when you are with a group of people? 
• Do you have difficulty understanding people who speak quickly or with foreign dialects?
• Do you feel disadvantaged by one or more of the above problems?

About Dr. Angela Loucks Alexander 

Dr. Angela Loucks Alexander, Audiologist, specializes in diagnosing and treating Auditory Processing Disorder (APD). Angela’s TEDx Talk “Escaping the Hidden Prison of Auditory Processing Disorder” was the most-watched TEDx worldwide in September 2021 and has more than one million views. She directs the Auditory Processing Institute, where she trains audiologists and speech-language pathologists to provide APD services. She has also created an online, searchable map to help clients find the help they need at www.APDsupport.com/apdmap.

About Dr. Robert DiSogra

Dr. Robert DiSogra, AuD, is a widely recognized pioneer in audiology. He is a well-known national and international lecturer, teacher, and author on various audiology topics, especially pharmaceutical side effects on hearing and balance and COVID-19 topics. 

About Auditory Processing Institute

Auditory Processing Institute trains audiologists and speech-language pathologists to help people with auditory processing disorder. We offer person-centered care and use the latest research and technology to provide effective treatments. We are proud to be a leading authority of clinical auditory processing services and are committed to making a positive difference in the lives of those we serve.

Please see additional photos and content here.  

Contact: 
Angela Alexander 
[email protected] 

Contact Information:

Bob DiSogra

Audiologist Consultant

[email protected]

Angela Alexander

Director of Education

[email protected]

+61403700643

Related Files
COVID 19 Brain Fog – final cut.mp4
Long COVID Brain Fog Could Be Auditory Processing Disorder DRAFT.docx

Original Source:

Auditory Processing Institute Study Finds Long COVID ‘Brain Fog’ Linked to Auditory Processing Disorder, an Underdiagnosed Neurological Disorder